Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruirui Jing

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Frontiers in Immunology|May 22, 2023
Incidence, clinical characteristics and prognosis of tumor lysis syndrome following B-cell maturation antigen-targeted chimeric antigen receptor-T cell therapy in relapsed/refractory multiple myelomaQiqi Zhang, Cheng Zu, Ruirui Jing, et al.
Cell Transplantation|January 6, 2024
Relapsed/Refractory Peripheral T-Cell Lymphoma-Associated Hemophagocytic Lymphohistiocytosis With UNC13D and CD27 Germline MutationsTingting Yang, Rongrong Chen, Mingming Zhang, et al.
Cell|July 31, 2020
Multiple Signaling Roles of CD3ε and Its Application in CAR-T Cell TherapyWei Wu, Qiuping Zhou, Takeya Masubuchi, et al.
Small Methods|December 20, 2021
Cas9-Cleavage Sequences in Size-Reduced Plasmids Enhance Nonviral Genome Targeting of CARs in Primary Human T CellsRuirui Jing, Peng Jiao, Jiangqing Chen, et al.
Cell Discovery|August 16, 2022
Treatment of allergic eosinophilic asthma through engineered IL-5-anchored chimeric antigen receptor T cellsSisi Chen, Gaoying Chen, Fang Xu, et al.
Cell Metabolism|January 3, 2024
Mitochondrial isocitrate dehydrogenase impedes CAR T cell function by restraining antioxidant metabolism and histone acetylationXiaohui Si, Mi Shao, Xinyi Teng, et al.
The New England Journal of Medicine|April 24, 2024
Sequential CD7 CAR T-Cell Therapy and Allogeneic HSCT without GVHD ProphylaxisYongxian Hu, Mingming Zhang, Tingting Yang, et al.
Nature Cancer|June 10, 2026
Iron-mediated ferroptosis impairs CAR-T cell function and antitumor efficacyDelin Kong, Tingting Yang, Mengyu Zhao, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Frontiers in Immunology|May 22, 2023
Incidence, clinical characteristics and prognosis of tumor lysis syndrome following B-cell maturation antigen-targeted chimeric antigen receptor-T cell therapy in relapsed/refractory multiple myelomaQiqi Zhang, Cheng Zu, Ruirui Jing, et al.
Cell Transplantation|January 6, 2024
Relapsed/Refractory Peripheral T-Cell Lymphoma-Associated Hemophagocytic Lymphohistiocytosis With UNC13D and CD27 Germline MutationsTingting Yang, Rongrong Chen, Mingming Zhang, et al.
Cell|July 31, 2020
Multiple Signaling Roles of CD3ε and Its Application in CAR-T Cell TherapyWei Wu, Qiuping Zhou, Takeya Masubuchi, et al.
Small Methods|December 20, 2021
Cas9-Cleavage Sequences in Size-Reduced Plasmids Enhance Nonviral Genome Targeting of CARs in Primary Human T CellsRuirui Jing, Peng Jiao, Jiangqing Chen, et al.
Cell Discovery|August 16, 2022
Treatment of allergic eosinophilic asthma through engineered IL-5-anchored chimeric antigen receptor T cellsSisi Chen, Gaoying Chen, Fang Xu, et al.
Cell Metabolism|January 3, 2024
Mitochondrial isocitrate dehydrogenase impedes CAR T cell function by restraining antioxidant metabolism and histone acetylationXiaohui Si, Mi Shao, Xinyi Teng, et al.
The New England Journal of Medicine|April 24, 2024
Sequential CD7 CAR T-Cell Therapy and Allogeneic HSCT without GVHD ProphylaxisYongxian Hu, Mingming Zhang, Tingting Yang, et al.
Nature Cancer|June 10, 2026
Iron-mediated ferroptosis impairs CAR-T cell function and antitumor efficacyDelin Kong, Tingting Yang, Mengyu Zhao, et al.
Pageof 3